Global Anti-Infective Drugs Market: Growth, Trends, and Projections for 2031

𝙂𝙡𝙤𝙗𝙖𝙡 𝘼𝙣𝙩𝙞-𝙄𝙣𝙛𝙚𝙘𝙩𝙞𝙫𝙚 𝘿𝙧𝙪𝙜𝙨 𝙈𝙖𝙧𝙠𝙚𝙩: 𝙊𝙫𝙚𝙧𝙫𝙞𝙚𝙬 𝙖𝙣𝙙 𝙋𝙧𝙤𝙟𝙚𝙘𝙩𝙞𝙤𝙣𝙨

The global anti-infective drugs market continues to exhibit strong growth, underpinned by factors such as the high prevalence of viral diseases, growing awareness about infectious diseases, and advancements in treatment options. With a value of US$ 139.1 billion in 2022, the market is projected to expand at a Compound Annual Growth Rate (CAGR) of 4.0% from 2023 to 2031, reaching a value exceeding US$ 177.9 billion by 2031.

𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗮 𝘀𝗮𝗺𝗽𝗹𝗲 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗿𝗲𝗽𝗼𝗿𝘁 𝗮𝘁 (𝗨𝘀𝗲 𝗖𝗼𝗿𝗽𝗼𝗿𝗮𝘁𝗲 𝗠𝗮𝗶𝗹 𝗜𝗱 𝗳𝗼𝗿 𝗤𝘂𝗶𝗰𝗸 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗲) -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41204&utm_source=OpenPR_Ajay&utm_medium=OpenPR

𝙁𝙖𝙘𝙩𝙤𝙧𝙨 𝘿𝙧𝙞𝙫𝙞𝙣𝙜 𝙈𝙖𝙧𝙠𝙚𝙩 𝙂𝙧𝙤𝙬𝙩𝙝

𝙏𝙝𝙚 𝙢𝙖𝙧𝙠𝙚𝙩'𝙨 𝙜𝙧𝙤𝙬𝙩𝙝 𝙞𝙨 𝙛𝙪𝙚𝙡𝙚𝙙 𝙗𝙮 𝙢𝙪𝙡𝙩𝙞𝙥𝙡𝙚 𝙛𝙖𝙘𝙩𝙤𝙧𝙨, 𝙞𝙣𝙘𝙡𝙪𝙙𝙞𝙣𝙜:

Prevalence of Viral Diseases: The rise in viral diseases globally, including emergent diseases like avian flu and swine flu, has driven the demand for effective anti-infective drugs.

Awareness and Treatment Options: Increased awareness among consumers about infectious diseases and the available treatment options has encouraged market growth.

Government Funding: Government initiatives to enhance drug approvals and support R&D efforts have contributed to the expansion of the anti-infective drugs market.

R&D and Technological Advancements: Growth in research and development activities, coupled with technological advancements, has paved the way for innovative drug solutions.

𝗕𝘂𝘆 𝘁𝗵𝗶𝘀 𝗣𝗿𝗲𝗺𝗶𝘂𝗺 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 | 𝗜𝗺𝗺𝗲𝗱𝗶𝗮𝘁𝗲 𝗗𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗔𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗮𝘁 -

https://www.transparencymarketresearch.com/checkout.php?rep_id=41204<ype=S&utm_source=OpenPR_Ajay&utm_medium=OpenPR

𝘾𝙝𝙖𝙡𝙡𝙚𝙣𝙜𝙚𝙨 𝙖𝙣𝙙 𝙍𝙚𝙨𝙩𝙧𝙖𝙞𝙣𝙩𝙨

While the market shows promising growth, challenges such as the potential side effects of anti-infective drugs and resource shortages in low- and middle-income countries may restrain market expansion.

𝙄𝙢𝙥𝙖𝙘𝙩 𝙤𝙛 𝘾𝙊𝙑𝙄𝘿-19

The COVID-19 pandemic significantly impacted the global market for anti-infective drugs. These drugs played a crucial role in preventing the spread of the SARS-CoV-2 virus. The pandemic prompted increased investment in R&D, leading to the development of new antiviral drugs. Notably, the approval of oral antiviral drugs like Paxlovid for COVID-19 treatment marked a significant milestone in the industry.

𝙎𝙚𝙜𝙢𝙚𝙣𝙩𝙖𝙩𝙞𝙤𝙣 𝙖𝙣𝙙 𝙈𝙖𝙧𝙠𝙚𝙩 𝘿𝙮𝙣𝙖𝙢𝙞𝙘𝙨

The anti-infective drugs market encompasses various drug classes, including antibacterials, antivirals, antifungals, and others. Among these, the antivirals segment is expected to dominate the market due to the rise in new infectious diseases. Initiatives such as licensing agreements and increased production are boosting the growth of antiviral drugs.

𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗰𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗿𝗲𝗽𝗼𝗿𝘁 𝗮𝘁 -

https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=41204&utm_source=OpenPR_Ajay&utm_medium=OpenPR

𝘿𝙞𝙨𝙩𝙧𝙞𝙗𝙪𝙩𝙞𝙤𝙣 𝘾𝙝𝙖𝙣𝙣𝙚𝙡𝙨 𝙖𝙣𝙙 𝙍𝙚𝙜𝙞𝙤𝙣𝙖𝙡 𝘼𝙣𝙖𝙡𝙮𝙨𝙞𝙨

Retail pharmacies are projected to lead distribution channels, driven by the proliferation of such pharmacies and the presence of knowledgeable pharmacists for prescription review.

Geographically, North America held the largest market share in 2022, attributed to robust healthcare infrastructure and well-established distribution channels. The Asia Pacific region is expected to witness rapid market growth due to its economic stability, rising disposable income, and a substantial number of generic companies.

𝙆𝙚𝙮 𝙋𝙡𝙖𝙮𝙚𝙧𝙨 𝙖𝙣𝙙 𝘿𝙚𝙫𝙚𝙡𝙤𝙥𝙢𝙚𝙣𝙩𝙨

Prominent players in the global anti-infective drugs market include Pfizer Inc., Gland Pharma Ltd., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., Novartis AG, and more. These companies are actively pursuing mergers, acquisitions, and new product development strategies to harness revenue opportunities.

𝗠𝗼𝗿𝗲 𝗧𝗿𝗲𝗻𝗱𝗶𝗻𝗴 𝗥𝗲𝗽𝗼𝗿𝘁𝘀 𝗯𝘆 𝗧𝗿𝗮𝗻𝘀𝗽𝗮𝗿𝗲𝗻𝗰𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 -

Cold Plasma Market

https://www.globenewswire.com/en/news-release/2023/03/30/2638299/0/en/Cold-Plasma-Market-Size-to-Cross-USD-17-3-Bn-by-2032-with-CAGR-of-19-3-Exclusive-Study-by-TMR.html

MicroRNA Market

https://www.globenewswire.com/en/news-release/2023/03/30/2638271/0/en/MicroRNA-Market-Size-to-Reach-USD-15-5-Bn-by-2033-TMR-Study.html

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀 𝗧𝗿𝗮𝗻𝘀𝗽𝗮𝗿𝗲𝗻𝗰𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝘀

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.